Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-10 Protein

This Recombinant IL-10 protein is expressed in Escherichia coli (E. coli) and has been mentioned in 2+ publications.
Catalog No. ABIN1305072

Quick Overview for IL-10 Protein (ABIN1305072)

Target

See all IL-10 (IL10) Proteins
IL-10 (IL10) (Interleukin 10 (IL10))

Protein Type

Recombinant

Biological Activity

Active

Origin

  • 25
  • 16
  • 8
  • 6
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Source

  • 40
  • 22
  • 16
  • 8
  • 3
  • 1
  • 1
  • 1
Escherichia coli (E. coli)

Application

ELISA, Functional Studies (Func), Intracellular Flow Cytometry (ICFC), Blocking Reagent (BR)

Purity

≥ 95 %
  • Brand

    BD Pharmingen™

    Specificity

    Bioassay: The activity range is measured in a proliferation assay using MC/9 indicator cells. Cells were co-stimulated with recombinant mouse IL-4 (Cat. No. 550067) at 50 pg/ml and were incubated for 24 hours prior to being pulsed. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    Specific Activity: 0.5 - 3.3 x 10^7 Units/mg (Unit is defined as the amount of material required to stimulate a half-maximal response at cytokine saturation).
    ED50: 0.3 - 2.0 ng/ml
    Observed dose response: >250 fold

    Characteristics

    Recombinant human IL-10 is supplied as a frozen, sterile-filtered aqueous buffered solution containing glycerol and biotechnology grade, low endotoxin bovine serum albumin, with no preservatives. Recombinant human IL-10 was purified by immunoaffinity chromatography and was found to be > 95% pure by SDS-PAGE analysis, and an absorbance assay based on the Beers-Lambert law.

    Purification

    Immunoaffinity Chromatography
    Recombinant human IL-10 (Cat No. 554611) is supplied as a frozen liquid comprised of 0.22 μm sterile-filtered aqueous buffered solution, containing glycerol and bovine serum albumin, with no preservatives. Recombinant human IL-10 is ≥ 95 % pure as determined by SDS-PAGE analysis, and an absorbance assay based on the Beers-Lambert law. The endotoxin level is ≤ 0.1 ng per μg of human IL-10, as measured in a chromogenic LAL assay.

    Sterility

    0.22 μm filtered

    Endotoxin Level

    The endotoxin level is ≤ 0.1 ng per µg of hIL-10, as measured in a chromogenic LAL assay.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Application Notes

    ELISA Standard: Recombinant human IL-10 is useful as a quantitative standard for measuring human IL-10 protein levels in an IL-10 specific sandwich ELISA with the purified JES3-9D7 antibody (Cat. No. 554705) as a capture antibody and the biotinylated JES3-12G8 antibody (Cat. 554611) as the detection antibody. To obtain linear standard curves, doubling dilutions of this human IL-10 standard from ~2,000 to 15 pg/ml should be included in each ELISA plate.
    Note: This ELISA pair is recommended primarily for measuring cytokine from experimental cell culture systems. These ELISA reagents are not recommended for assaying serum or plasma samples. For measuring human IL-10 in serum or plasma the BD OptEIA™ Human IL-10 ELISA Set (Cat. No. 555157) and the BD OptEIA™ Human IL-10 ELISA Kit (Cat. No. 550613) are specially formulated and recommended.
    Ligand Blocking Control for Immunofluorescent Staining of Cytokines: Recombinant human IL-10 can be used as a blocking control to demonstrate the specificity of IL-10 staining by our conjugated anti-IL-10 antibodies (for example Cat. No. 554498, Cat. No. 554706, Cat. No. 554707).

    Comment

    BD Pharmingen™ Recombinant Human IL-10 - Reactivity Hu

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    Frozen aqueous buffered solution containing BSA and glycerol.

    Handling Advice

    Interleukin-10 (IL-10), originally known as Cytokine Synthesis Inhibitory Factor (CSIF), is an 18.5 kD protein that shares over 80 % sequence homology with the Epstein-Barr Virus protein BCRFI. The reported biological activities of IL-10, which may be interrelated, include inhibition of macrophage-mediated cytokine synthesis, suppression of the delayed type hypersensitivity response, and stimulation of the TH2 cell response, which results in elevated antibody production. The net effect of IL-10 action appears to be the inhibition of proinflammatory T cell mediated immunity.

    Storage

    -80 °C

    Storage Comment

    Store product at -80°C prior to use or for long term storage of stock solutions. Rapidly thaw and quick-spin product prior to use. Avoid multiple freeze-thaws of product. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
  • Howard, OGarra, Ishida, de Waal Malefyt, de Vries: "Biological properties of interleukin 10." in: Journal of clinical immunology, Vol. 12, Issue 4, pp. 239-47, (1992) (PubMed).

    Vieira, de Waal-Malefyt, Dang, Johnson, Kastelein, Fiorentino, deVries, Roncarolo, Mosmann, Moore: "Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, Issue 4, pp. 1172-6, (1991) (PubMed).

  • Target

    IL-10 (IL10) (Interleukin 10 (IL10))

    Alternative Name

    IL-10

    Background

    Interleukin-10 (IL-10), originally known as Cytokine Synthesis Inhibitory Factor (CSIF), is an 18.5 kD protein that shares over 80 % sequence homology with the Epstein-Barr Virus protein BCRFI. The reported biological activities of IL-10, which may be interrelated, include inhibition of macrophage-mediated cytokine synthesis, suppression of the delayed type hypersensitivity response, and stimulation of the TH2 cell response, which results in elevated antibody production. The net effect of IL-10 action appears to be the inhibition of proinflammatory T cell mediated immunity.

    Pathways

    Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
You are here:
Chat with us!